The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
If you're there wyn, does the chart for Abingdon show any promise? They have a new (saliva) pregnancy test out soon.
I sold my ISA abingdon without remembering that I'd also go a very small number in my SIPP. I might add to them as otherwise they aren't worth selling..
https://www.similarweb.com/website/evesleep.co.uk/#traffic
Way below the number of website visits 'we' used to get before the slump. Even if CC had managed to hang on to the business for longer it wouldn't have turned around any time soon.
fingers crossed D.
AVCT should clarify whats currently going on. I have no feel for how it will go, historically it will be more delays... Hopefully LD will be an area of good news but I would just love a buyout (300p would do!) now as this is a serial disappointer which is so frustrating when the tech is so promising.
Harl is very early days but at least has huge upside potential.
Its a game, thats for sure...
Hi both,
I still have angle bought above 100p so not too happy, but not a big investment so not (now) worth selling. Just wish I could learn to sell on the way down..
Almost all my hopes seem rest on avct.
Tiziana now $TLSA had a good run last week and things can turn around quickly if the news turns positive for almost any company. Angle might still recover for me and if I end up selling some avct at a profit I might end up with more angle; stranger thins have happened.
I've dipped my toe in at HARL and have a tiny profit!
Hi Guys, Angle disappointed after the wait for FDA approval. Still at leat there was an oportunity to make mony in the expectation.
Right now 219.5p is a support/resistance, with maybe 22.5-23.5p as a target. The big target would be 30p which is a fair way from her (50% gain potential).
Right now my money is tied up and working ok , so I am not tempted by this one currently.
GL
I see ur comment on Angle D-Geeman, I am also following and have position now. Seems like an earlier reversal trend occurring but not to sure. I think if can go above 20p this may confirm this. What you thoughts? Also Wyn whether ur following Angle too? Thanks
For those interested, filing on 28th Feb, with all money owed: https://find-and-update.company-information.service.gov.uk/company/09261636/filing-history
Eve on Similarweb: https://www.similarweb.com/website/evesleep.co.uk/#ranking
No spare cash to invest till something pays off but I wonder about RUA LIFE SCIENCES PLC (RUA) chart looking good. It tends to ebb and flow without much changing so could be another false hope.
I suppose it might fit well, and AI is hot technology. But there must be dozens of possibles....
'About Imaging Biometrics, LLC
IQ-AI Limited, (LON: IQAI) (OTCQB: IQAIF), the parent company of Wisconsin-based Imaging Biometrics, LLC (IB), is focused on delivering quantitative imaging platforms and therapeutics that transform how clinicians diagnose and treat patients more efficiently and effectively. For more information about Imaging Biometrics, visit the company's website at www.imagingbiometrics.com.'
I hadn't thought of that. But the two approaches would complement each other as a treatment for solid tumours; GaM slowing the growth while AVA6K picks off the cancer cells.
I think that the main man at IQAI (TB) is pretty ruthless and owns a lot of the shares himself, or the family do. It wouldn't be cheap.
Reading the IQAI bb this was spotted on the FDA site in the morning by one poster, but not RNS'd till late afternoon, then generated 20+% rise in a few minutes
Missed opportunity for a quick profit!
Are you thinking that AVCT could buy them or be a candidate, for their DX business?
'applies to other solid tumors as well,” he adds.''
Just thinking of combination therapies – or possible competition I suppose
sorry D, I am not on your wavelength.. What am I missing?
Ring any bells wyn?
'Drs. Chitambar and Kathleen Schmainda, PhD, discovered that gallium maltolate (GaM) significantly slowed the growth, and reduced the size, of glioblastoma.'
'GaM, originally developed by Harvard and Stanford educated scientist Lawrence R. Bernstein, PhD, is an orally available form of the metal gallium, which, in the body, shares many chemical properties with the highly oxidized form of iron, called Fe(III). Numerous studies examining the relationship between iron and cancer show that increased levels of iron in the body can be associated with increased cancer risk and severity, because cancer cells depend on iron to multiply and spread. Because of gallium’s similarity to Fe(III), it enters cancer cells instead of iron, preventing their multiplication.
“The discovery that GaM has anticancer activity against glioblastoma in pre-clinical studies is extremely exciting; it opens the door for developing it as a drug for treatment of glioblastoma in patients,” says Christopher Chitambar, MD, Emeritus Professor of Medicine and Biophysics, Division of Hematology and Oncology at MCW. “The anticancer mechanism of GaM applies to other solid tumors as well,” he adds.'
well done!
Seems both my posts were correct! Just received Orphan status in the US.
QAI / Iq-ai seems I wrote too soon!
ReplyRecommendReport Post
D-Geeman
Posts: 3,714
Price: 0.00
No Opinion
RE:
IQAI / Iq-ai seems to be bubbling a little.
Well, as always D, you are very generous and supportive with your view of me relative to others, so thanks again for having the courage to post it.
I was really looking forward to this week and today, having thought long and hard over the weekend about what was coming next, I figured it would move to the recent high of 185p because SD confirmed the Jan RNS and then as it seemed to outperform or at least back up the hype with real data, it would move to 200p plus and thought AVCT would have 5 continuous days of rises!!
So as always with this one, there are other things going on which we can only guess at.
Somebody posted that maybe no one has contacted AVCT about buying or licensing the tech and that they will be forced to go it alone.... Its possible I guess.
I think the SP reflects the extension to the trial because it seems to be out of AVCT's hands and just because AS says 6 months does not mean it will finish in the summer. The uncertainty of actual progress in terms of the trial, ie one bit finishing and the next bit starting, is I think the most likely reason for some selling as its gone a bit back burner (again).
Hey ho....
Thanks very much for that wyn. (We should soon find out if others are still looking in on eve sleep BB.)
Whatever happens with AVCT long run the SP will surely have peaks and probably above £2. I, like many others I suspect, put a more in with the intention of selling before SD, before paying off some of the mortgage. That money is stuck now but the results are so good that I'm not unduly worried as it should come good, just not in the two planned weeks I had hoped for. It will be difficult to put my SIPP tax relief into WOSG as planned if AVCT is still at today's price or lower, but I should try to stick to my plan. WOSG does seem to fluctuate around 10% which is worth having.
I can't see AVCT going the way of Angle as dox is such a big market whereas Angle is attempting something new.
I suspect a lot of people get useful info from your posts but then publicly place themselves in the other camp, to stay popular.
Hi D, yes it was a surprise to me too. Still, it will be more instructive to me to see where it closes.
The trouble is I think now, that there is no clear path to make this commercial. Sure there are pathways, but its not clear which one will be taken or when. I think this is exacerbated by AS himself.
The BB won't hear a word against him but he will have caused a lot of people to take a big hit on the LFT debacle which whether he meant it or not, pumped it to the heavens.
And he is doing it again, but this time we all hope its justified. It looks like it is, so I think its just a wait and see now, but that could be a little while. Meantime whats happening with DE5? it drives me mad! :0))
Like I say although I am in a minority of probably one, I don't trust him enough to take what he says at face value and I think there is much more he knows that he is deliberately keeping quiet about.
I'm surprised at the fall first thing today but have no cash to take advantage. They seem to have a sure-fire winner.
Thanks Ci, fingers crossed and all that.
A close above 17.25p would be very bullish and I think would confirm a reversal was taking place. (The caveat is always it could be a false breakout however if it did fall back into a trading range I would not sell unless it fell now to 14-14.5p)
Anyway, assuming all is good, then the next big target would be a close above 22.5p which then would put the recent all time high of 25.90p in play but I would not see this as particularly significant at this stage in the great scheme of things.(the 22.5p is the one for me.) After that its about 40p but we are going back a year or so so by then the chart will have thrown up new lines and supports etc
What can get the taste buds going is that the high 10 years ago was around 1475p. I am not saying its going back there ever, but there does seem scope now for some very good appreciation. Just my opinion etc etc
Wyn, very good call! good for u. What's your analysis on where it goes next from TA? GL! Hope it generates a massive return for u.